Stock FATE FATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Fate Therapeutics, Inc.

Equities

FATE

US31189P1021

Market Closed - Nasdaq
Other stock markets
 21:00:00 15/05/2024 BST 		5-day change 1st Jan Change
4.24 USD +0.47% Intraday chart for Fate Therapeutics, Inc. +14.59% +13.37%
05-10 Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating MT
05-10 Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
FATE THERAPEUTICS, INC.
Bio Therapeutic Drugs
+0.47%+14.59%+13.37%-20.45%-76.92% 480M
Bearish
Neutral
Bullish
  1. Stock Market
  2. Equities
  3. FATE Stock
  4. Charts Fate Therapeutics, Inc.
  5. Relative Strength Chart